EA
ENFN

Emerald Advisers’s Enfusion, Inc. ENFN Stock Holding History

Emerald Advisers’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-187,913
Closed -$2.39M – 276
2022
Q1 		$2.39M Buy
187,913
+18,843
+11% +$288K 0.09% 126
2021
Q4 		$3.54M Buy
+169,070
New +$3.42M 0.13% 124

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers's ENFN Position: Q2 2022 in Review

Emerald Advisers sold out of Enfusion, Inc. (ENFN) in Q2 2022, closing a stake of 187,913 shares — an estimated $2.39M sold.

Emerald Advisers first reported a position in ENFN in Q4 2021 and held it in 2 quarters. The position peaked at $3.54M in Q4 2021. 62 funds tracked by Wall St. Rank hold ENFN as of Q2 2022.

  • Emerald Advisers reported no remaining Enfusion, Inc. position as of Q2 2022 after selling out during the quarter.
  • Emerald Advisers sold 187,913 Enfusion, Inc. shares in Q2 2022, an estimated $2.39M.
  • Emerald Advisers first reported a position in Enfusion, Inc. in Q4 2021 and held it in 2 quarters.
  • Emerald Advisers's Enfusion, Inc. position peaked at $3.54M in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2022.

Based on Emerald Advisers's 13F filing for Q2 2022, filed 29 Jul 2022.